Single‐Dose Pharmacokinetics of Oral Ciprofloxacin in Patients With Cystic Fibrosis

The Journal of Clinical Pharmacology

Volumn 26, Issue 3, 1986, Pages 222-226

  Goldfarb, Johanna ^a   Wormser, Gary P ^a   Inchiosa, Mario A ^a   Guideri, Giancarlo ^a   Diaz, Magaly ^a   Gandhi, Ruta ^a   Goltzman, Carey ^a   Mascia, Armond V ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; PLACEBO;

BRONCHOPNEUMONIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG SPUTUM LEVEL; DRUG THERAPY; HUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; THERAPY;

EID: 0022651195     PISSN: 00912700     EISSN: 15524604     Source Type: Journal    
DOI: 10.1002/j.1552-4604.1986.tb02938.x     Document Type: Article

References (15)

1. Antibacterial activities of ciprofloxacin, norfloxacin, onolinic acid, cinoaxacin, and nalidixic acid
2. Comparative activities of ciprofloxacin (BAY 0 9867), norfloxacin, pipemidic acid and nalidixic acid
3. Pharmacokinetics and tissue penetration of ciprofloxacin
4. Multiple‐dose pharmacokinetics and safety of ciprofloxacin in normal volunteers
5. Pharmacokinetics of ciprofloxacin after oral and intravenous administration in healthy volunteers
6. Multiple‐dose ciprofloxacin kinetics in normal subjects
7. Pharmacokinetics of ciprofloxacin after oral and parenteral administration
8. The pharmacokinetics and serum and urine bactericidal activity of ciprofloxacin
9. Aminoglycoside clearance in patients with cystic fibrosis
10. Enhanced renal excretion of dicloxacillin in patients with cystic fibrosis
11. Dosing implications of altered gentamicin disposition in patients with cystic fibrosis
12. Pharmacokinetics of methicillin in patients with cystic fibrosis
13. Long‐term study of one hundred five patients with cystic fibrosis
14. A new prognostic score and clinical evaluation system for cystic fibrosis
15. Determination of ciprofloxacin (BAY 0 9867) in biological fluids by high‐performance liquid chromatography